• Markets
• News
• Learn

With U.S. stocks under pressure and growth expectations being questioned, many investors are quietly hunting for steadier ground. When technology and consumer discretionary stocks struggle, attention often shifts to large dividend payers and value stocks that some investors see as potential ballast for a tougher market mood. This article walks through three stocks from our Defensive, Dividend-Paying Value Stocks screener that appear particularly exposed to the latest inflation, earnings and jobs data narrative.

The stocks in the list below are just a starting sample, and the full screen surfaced 31 more large cap companies with similar dividend, value and risk characteristics that are not covered here but may also interest you. If you want to identify stronger fits for your own risk profile and income goals, head straight into the Defensive, Dividend-Paying Value Stocks screener to filter, analyze and focus on the combinations that matter most to you.

Coca-Cola FEMSA is a large Latin American Coca-Cola bottler that fits the defensive, dividend-paying theme through its consumer staples focus and history of steady cash generation. The company generates around MX$296.2b from non-alcoholic beverages across soft drinks, water and other ready-to-drink categories, supported by a broad footprint in Mexico, Brazil, Central America and the rest of South America. With a market cap of about US$24.1b, it offers large cap scale and income exposure outside the U.S. market.

For investors unsettled by pressure on growth stocks, Coca-Cola FEMSA offers a different mix of qualities. You get a consumer staples business with broad reach across Mexico and Brazil, a record of cash generation that supports dividends, and management focused on efficiency and digital tools to keep margins in check. At the same time, dependence on a handful of key countries, higher reliance on external funding and volume swings discussed on recent earnings calls show that this is not a risk free income play. If you are weighing whether that trade off is worth it, the real story sits in how those earnings, dividends and regional exposures come together over the next few years.

Coca-Cola FEMSA’s cash generation and dividend story can look straightforward, yet the real puzzle sits in how those earnings, payout capacity and regional risks fit together in the analysis report for Coca-Cola FEMSA. de

National Fuel Gas is a diversified U.S. energy company that fits this defensive, dividend-paying value screen through its mix of regulated utility, pipeline and storage, and upstream gas operations. It earns about $1.3b from Integrated Upstream and Gathering, $938 million from its Utility segment, and $431 million from Pipeline and Storage, with all reported revenue sourced in the United States, and has a market cap of about $7.8b.

For investors looking beyond pressured growth stocks, National Fuel Gas offers a regulated utility and pipeline backbone combined with upstream gas exposure that can support steady earnings and dividend potential even as inflation and rate worries unsettle the broader market. The company is leaning into long-life Marcellus assets and a growing regulated footprint, but that comes with higher debt and rising labor and materials costs that investors need to track. If you want to understand how its dividend record, Ohio gas acquisition and capital plan balance against those transition and leverage risks, the real detail sits in how its cash flows, regulation and growth projects connect over the next few years.

National Fuel Gas combines regulated stability with upstream gas exposure that many investors may be underestimating. See how its cash flows, leverage and Ohio deal work together in the 4 key rewards and 2 important warning signs

Quest Diagnostics is a large U.S. healthcare company in diagnostic testing. It fits the defensive, dividend-paying value theme by offering recurring demand for lab services and a history of returning cash to shareholders. The company generates about US$11.3b from its core Diagnostic Information Services business and US$253 million from DS Revenues, almost all of it in the United States, supported by a nationwide network of labs, service centers and digital health tools. With a market cap of about US$26.9b, Quest Diagnostics gives investors large cap healthcare exposure tied to everyday testing needs rather than discretionary spending.

Quest Diagnostics may appeal if you want healthcare exposure that leans on routine and advanced testing instead of consumer cycles. The company is pushing into higher value areas such as Alzheimer’s blood tests, oncology and consumer wellness, which could help support cash flow and a steady dividend even as tech and consumer stocks feel pressure. At the same time, you need to weigh reimbursement and policy risks, a heavier debt load and ongoing price pressure from powerful insurers and health systems. If you want to see how those trade offs look when you put earnings quality, valuation signals and dividend resilience side by side, this is a business worth a closer look before earnings and jobs data reset market expectations again.

Quest Diagnostics is shifting toward higher value testing while still leaning on routine demand, which many investors may be underestimating. See how earnings quality, cash returns and policy risk intersect in the analysis report for Quest Diagnostics

Seeking Alternatives Before Momentum Shifts

Fresh stock ideas do not stay under the radar for long. Screens fill up fast once momentum builds and breakouts get caught by the crowd. Check the data while it matters and get in early.

• Target dependable income by reviewing a curated 12 dividend fortresses that focuses on durable payouts while growth stories swing around each new data release.
• Hunt for quality on sale with a hand picked 49 high quality undervalued stocks before renewed momentum sends solid balance sheet stocks flying out of value territory.
• Position ahead of the next infrastructure push by scanning a focused 38 power grid technology and infrastructure stocks while many investors still overlook grid technology and equipment suppliers.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com